DeFronzo RA. et al "Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease"   Diabetes Care. 1991 Mar;14(3):173-94
Zhang Y. et al "Mitochondrial inhibitor as a new class of insulin sensitizer"   Acta Pharm Sin B. 2012 Aug;2(4):341-349
†The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.